17 July 2017

VEROVACCiNES GmbH founded in Halle (Saale), Germany.

VEROVACCiNES GmbH is a successful spin-off from the Martin Luther University Halle-Wittenberg, Germany. The co-founders Dr. Hanjo Hennemann and Prof. Dr. Sven-Erik Behrens entered the management of the company as managing directors. “We are very pleased to get the company started. After achieving a positive votum for our funding application in the federal BMBF GO-Bio-funding program, making VEROVACCiNES eligible for 3.1 m euros funding, it made sense to get the company off the ground. We plan to close the financing round soon and to continue the development of our vaccine programs.” Dr. Hanjo Hennemann said.